FLUIDDA is the world leader in the field of Functional Respiratory Imaging (FRI) research and development. The company’s proprietary FRI technology offers pharmaceutical companies and healthcare providers a unique entry point into personalized medicine for patients suffering from respiratory diseases and sleep-related breathing disorders. Implementation of FRI in the clinical practice creates significant added value to the current healthcare standard in the respiratory field.
Some significant facts about FLUIDDA
- FLUIDDA was founded in 2005. Its Head Office is located in Kontich Belgium, with subsidiaries in India and the US.
- The executive officers are graduates of engineering and aerospace engineering programs focusing on computational fluid dynamics (CFD), a discipline used in the design of aircraft wings. At FLUIDDA, this expertise is applied to the diagnosis and monitoring of respiratory diseases.
- Flow simulations are combined with CT scans to provide a unique sensitive tool for phenotyping patients and monitoring the efficacy of novel respiratory drugs.
FLUIDDA developed its novel FRI technology in house and is now expanding its commercial portfolio.